Wie verlässlich ist Evidenz in der Medizin?
-
Erwin-Schrödinger-Saal
Plenary
/
in englischer SpracheIst die evidenzbasierte Medizin (EBM) verlässlicher als die klinische Erfahrung? Welche Grenzen hat die wissenschaftliche Evidenz? Wie kann die Kluft zwischen klinischer Forschung und der Praxis überbrückt werden?
| |||||
|
Prof. John IOANNIDIS
C.F. Rehnborg Professor in Disease Prevention and Director, Prevention Research Center, Stanford University School of Medicine, Stanford
| C.F. Rehnborg Chair in Disease Prevention at Stanford University, Stanford | |
| Professor of Medicine and Director of the Stanford Prevention Research Center, Stanford University School of Medicine, Stanford | |
| 1999-2003 | Chair, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina |
| 1990 | Study of Medicine, University of Athens |
| Doctorate in Biopathology | |
| Specialisation in Internal Medicine and Infectious Diseases, Harvard University and Tufts University, NIH - National Institutes of Health, Johns Hopkins University School of Medicine and Tufts University School of Medicine, Boston | |
| since 1996 | Adjunct Faculty, Tufts University School of Medicine, Boston |
| since 2002 | Professor, Tufts University School of Medicine, Boston |
| since 2008 | Leader, Genetics/Genomics Component of CTSI - Tufts Clinical and Translational Science Institute and CGEM - Center for Genetic Epidemiology and Modeling, Tufts Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston |
| Adjunct Professor of Epidemiology, Harvard School of Public Health, Boston | |
| Visiting Professor of Epidemiology and Bio Statistics, Imperial College, London |
Dr. Giulio SUPERTI-FURGA
Professor, Institute of Pharmacology, Medical University of Vienna; Scientific Director, CeMM - Research Center for Molecular Medicine, Austrian Academy of Sciences, Vienna
| 1987-1991 | Ph.D., Molecular Biology, University of Zurich |
| 1991-1993 | Postdoctoral fellow, EMBO and EU Postdoc EMBL - European Molecular Biology Laboratory, Heidelberg |
| 1993-2004 | Staff Scientist, Team Leader; EMBL - European Molecular Biology Laboratory, Heidelberg |
| 1997-2000 | Guest Professor, Molecular Biology, University of Bologna |
| 2000-2005 | Founder and Scientific Director, Cellzome AG and Inc., Heidelberg and Cambridge |
| 2005-2014 | Guest Professor, Molecular Pharmacology, Medical University of Vienna |
| since 2005 | Director, CeMM - Research Center for Molecular Medicine, Austrian Academy of Sciences, Vienna |
| since 2015 | Professor, Medical Systems Biology, Center for Physiology and Pharmacology, Medical University of Vienna |
| since 2017 | Member, Scientific Council of the European Research Council, Brussels |
